U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07161869) titled 'Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)' on Aug. 28.
Brief Summary: In the POELH-II trial (Clinicaltrials.gov ID NCT05678218) patients with presumed resectable perihilar (pCCA), intrahepatic (iCCA) or mid-common bile duct (CBD) cholangiocarcinoma had the outcomes of their preoperative endoscopic ultrasound (EUS) registered. This EUS procedure was done systematically, targeting lymph nodes (LNs) with the aim to identify LN metastases preoperatively.
The goal of this follow-up observational cohort study (POELH-III) is to assess the yield of preoperative EUS, with an improved EUS approach. The EUS pro...